KR100830282B1 - 모락셀라 카탈리스로부터의 basb027 단백질 및유전자, 항원, 항체, 및 이들의 용도 - Google Patents
모락셀라 카탈리스로부터의 basb027 단백질 및유전자, 항원, 항체, 및 이들의 용도 Download PDFInfo
- Publication number
- KR100830282B1 KR100830282B1 KR1020007013705A KR20007013705A KR100830282B1 KR 100830282 B1 KR100830282 B1 KR 100830282B1 KR 1020007013705 A KR1020007013705 A KR 1020007013705A KR 20007013705 A KR20007013705 A KR 20007013705A KR 100830282 B1 KR100830282 B1 KR 100830282B1
- Authority
- KR
- South Korea
- Prior art keywords
- polypeptide
- seq
- polynucleotide
- host cell
- basb027
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9811945.6A GB9811945D0 (en) | 1998-06-03 | 1998-06-03 | Novel compounds |
| GB9811945.6 | 1999-03-08 | ||
| GB9905304.3 | 1999-03-08 | ||
| GBGB9905304.3A GB9905304D0 (en) | 1999-03-08 | 1999-03-08 | Novel compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020067024958A Division KR100911277B1 (ko) | 1998-06-03 | 1999-05-31 | 모락셀라 카탈리스로부터의 basb027 단백질 및 유전자,항원, 항체, 및 이들의 용도 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20010052552A KR20010052552A (ko) | 2001-06-25 |
| KR100830282B1 true KR100830282B1 (ko) | 2008-05-16 |
Family
ID=26313784
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020007013705A Expired - Fee Related KR100830282B1 (ko) | 1998-06-03 | 1999-05-31 | 모락셀라 카탈리스로부터의 basb027 단백질 및유전자, 항원, 항체, 및 이들의 용도 |
| KR1020077019114A Ceased KR20070089890A (ko) | 1998-06-03 | 1999-05-31 | 모락셀라 카탈리스로부터의 basb027 단백질 및 유전자,항원, 항체, 및 이들의 용도 |
| KR1020067024958A Expired - Fee Related KR100911277B1 (ko) | 1998-06-03 | 1999-05-31 | 모락셀라 카탈리스로부터의 basb027 단백질 및 유전자,항원, 항체, 및 이들의 용도 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020077019114A Ceased KR20070089890A (ko) | 1998-06-03 | 1999-05-31 | 모락셀라 카탈리스로부터의 basb027 단백질 및 유전자,항원, 항체, 및 이들의 용도 |
| KR1020067024958A Expired - Fee Related KR100911277B1 (ko) | 1998-06-03 | 1999-05-31 | 모락셀라 카탈리스로부터의 basb027 단백질 및 유전자,항원, 항체, 및 이들의 용도 |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US6803043B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1082435B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4503177B2 (cg-RX-API-DMAC7.html) |
| KR (3) | KR100830282B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1311820B (cg-RX-API-DMAC7.html) |
| AT (1) | ATE341628T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU738896B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR9911609A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2331196A1 (cg-RX-API-DMAC7.html) |
| CY (1) | CY1105820T1 (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ296086B6 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69933444T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1082435T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2274627T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUP0102235A3 (cg-RX-API-DMAC7.html) |
| IL (2) | IL139951A0 (cg-RX-API-DMAC7.html) |
| NO (1) | NO327201B1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ508617A (cg-RX-API-DMAC7.html) |
| PL (1) | PL198031B1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1082435E (cg-RX-API-DMAC7.html) |
| TR (1) | TR200003608T2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999063093A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0103171D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| US20030157522A1 (en) * | 2001-11-09 | 2003-08-21 | Alain Boudreault | Methods and reagents for peptide-BIR interaction screens |
| CN1674933B (zh) | 2002-08-02 | 2012-09-26 | 葛兰素史密丝克莱恩生物有限公司 | 疫苗组合物 |
| TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| WO2024017827A1 (en) | 2022-07-19 | 2024-01-25 | Glaxosmithkline Biologicals Sa | Continuous process for vaccine production |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9224584D0 (en) * | 1992-11-23 | 1993-01-13 | Connaught Lab | Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases |
| BE1006377A3 (fr) | 1992-11-24 | 1994-08-09 | Raffinerie Tirlemontoise Sa | Procede de separation d'une composition polydispersee de saccharides, produits obtenus par ce procede et utilisation des produits obtenus dans des compositions alimentaires. |
| US5807978A (en) * | 1995-06-07 | 1998-09-15 | Kokolus; William J. | Immunogenic peptides of prostate specific antigen |
| US6090576A (en) * | 1996-03-08 | 2000-07-18 | Connaught Laboratories Limited | DNA encoding a transferrin receptor of Moraxella |
| US6673910B1 (en) * | 1999-04-08 | 2004-01-06 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics |
-
1999
- 1999-05-31 EP EP99926507A patent/EP1082435B1/en not_active Expired - Lifetime
- 1999-05-31 CA CA002331196A patent/CA2331196A1/en not_active Abandoned
- 1999-05-31 CZ CZ20004510A patent/CZ296086B6/cs not_active IP Right Cessation
- 1999-05-31 CN CN998091995A patent/CN1311820B/zh not_active Expired - Fee Related
- 1999-05-31 HU HU0102235A patent/HUP0102235A3/hu unknown
- 1999-05-31 KR KR1020007013705A patent/KR100830282B1/ko not_active Expired - Fee Related
- 1999-05-31 AU AU43732/99A patent/AU738896B2/en not_active Ceased
- 1999-05-31 KR KR1020077019114A patent/KR20070089890A/ko not_active Ceased
- 1999-05-31 PL PL345193A patent/PL198031B1/pl not_active IP Right Cessation
- 1999-05-31 KR KR1020067024958A patent/KR100911277B1/ko not_active Expired - Fee Related
- 1999-05-31 US US09/701,711 patent/US6803043B1/en not_active Expired - Fee Related
- 1999-05-31 JP JP2000552287A patent/JP4503177B2/ja not_active Expired - Fee Related
- 1999-05-31 TR TR2000/03608T patent/TR200003608T2/xx unknown
- 1999-05-31 NZ NZ508617A patent/NZ508617A/en unknown
- 1999-05-31 AT AT99926507T patent/ATE341628T1/de active
- 1999-05-31 DE DE69933444T patent/DE69933444T2/de not_active Expired - Lifetime
- 1999-05-31 ES ES99926507T patent/ES2274627T3/es not_active Expired - Lifetime
- 1999-05-31 BR BR9911609-0A patent/BR9911609A/pt not_active Application Discontinuation
- 1999-05-31 DK DK99926507T patent/DK1082435T3/da active
- 1999-05-31 WO PCT/EP1999/003822 patent/WO1999063093A2/en not_active Ceased
- 1999-05-31 IL IL13995199A patent/IL139951A0/xx active IP Right Grant
- 1999-05-31 PT PT99926507T patent/PT1082435E/pt unknown
-
2000
- 2000-11-28 IL IL139951A patent/IL139951A/en not_active IP Right Cessation
- 2000-12-01 NO NO20006112A patent/NO327201B1/no not_active IP Right Cessation
-
2004
- 2004-07-22 US US10/896,725 patent/US7641910B2/en not_active Expired - Fee Related
-
2006
- 2006-12-01 CY CY20061101736T patent/CY1105820T1/el unknown
-
2009
- 2009-11-18 US US12/621,280 patent/US20100143412A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20100143412A1 (en) | Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses | |
| US20030161835A1 (en) | Polypeptides from moraxella (branhamella) catarrhalis | |
| US7592158B2 (en) | BASB019 proteins and genes from Moraxella catarrhalis, antigens, antibodies, and uses | |
| KR100610448B1 (ko) | 모락셀라 카탈리스로부터의 화합물 | |
| US7432366B2 (en) | Moraxella catarrhalis BASB034 polypeptides and used thereof | |
| US6706269B1 (en) | Moraxella catarrhalis PILQ proteins | |
| US6706271B1 (en) | Cloning of BASB023 antigen from Moraxella catarrhalis | |
| HK1037209B (en) | Proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses | |
| ZA200007108B (en) | BASB027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| R15-X000 | Change to inventor requested |
St.27 status event code: A-3-3-R10-R15-oth-X000 |
|
| R16-X000 | Change to inventor recorded |
St.27 status event code: A-3-3-R10-R16-oth-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| A201 | Request for examination | ||
| AMND | Amendment | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| AMND | Amendment | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
St.27 status event code: N-2-6-B10-B15-exm-PE0601 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| J201 | Request for trial against refusal decision | ||
| PJ0201 | Trial against decision of rejection |
St.27 status event code: A-3-3-V10-V11-apl-PJ0201 |
|
| A107 | Divisional application of patent | ||
| AMND | Amendment | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0104 | Divisional application for international application |
St.27 status event code: A-0-1-A10-A18-div-PA0104 St.27 status event code: A-0-1-A10-A16-div-PA0104 |
|
| PB0901 | Examination by re-examination before a trial |
St.27 status event code: A-6-3-E10-E12-rex-PB0901 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| B701 | Decision to grant | ||
| PB0701 | Decision of registration after re-examination before a trial |
St.27 status event code: A-3-4-F10-F13-rex-PB0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| FPAY | Annual fee payment |
Payment date: 20110428 Year of fee payment: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20120510 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20120510 |